Concepedia

Author

David Pearson

Novartis (Switzerland)

Also Known As

D E Pearson, D Pearson, D. E. Pearson, D. Pearson, D.E. Pearson, David E. Pearson, David Pearson, Emily Finzel, Stuart Parker

77

Publications

703

Citations

14

H-Index

73

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical ResearchUniversity of ChicagoNovartis (United States)Yale University
DP

About

David Pearson is an author at Novartis (Switzerland) specializing in engineering, medicine, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

6

6

197

2

Medicine

5

5

141

3

Social Sciences

3

3

69

4

Health Sciences

1

1

37

5

Natural Sciences

1

1

11

David Pearson

×

21

Publications

569

Citations

14

H-Index

YearCitations

Fourier transform infrared study of the variation in the oxidation of a coking coal

Paul C. Painter, Randy W. Snyder, David Pearson,

Fuel

1980

111

Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies

Ying Huang, Martin Sendzik, Jeff Zhang,

Journal of Medicinal Chemistry

2022

49

Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats.

R W Fuller, Susan K. Hemrick-Luecke, D T Wong,

Journal of Pharmacology and Experimental Therapeutics

1983

45

Mineral matter as a measure of oxidation of a coking coal

David Pearson, Y. T. John Kwong

Fuel

1979

40

Environmental Influences on Body Weight and Behavior in Developing Rats After Neonatal 6-Hydroxydopamine

David Pearson, Martin H. Teicher, Bennett A. Shaywitz,

Science

1980

38

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results

Ulrich Jaeger, Nina Worel, Joseph P. McGuirk,

Blood Advances

2022

37

Updated phase I study results of PHE885, a T-Charge manufactured BCMA-directed CAR-T cell therapy, for patients (pts) with r/r multiple myeloma (RRMM).

Adam S. Sperling, Benjamin A. Derman, Sarah Nikiforow,

Journal of Clinical Oncology

2023

34

Evaluation of cAMS for <sup>14</sup> C Microtracer ADME Studies: Opportunities to Change the Current Drug Development Paradigm

Frédéric Lozac’h, Simon Fahrni, Daniele De Maria,

Bioanalysis

2018

28

Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in &amp;lt;2 Days Using the T-Charge TM Platform

Adam S. Sperling, Sarah Nikiforow, Omar Nadeem,

Blood

2021

22

Radial arm maze performance in rats following neonatal dopamine depletion

David Pearson, Lisa A. Raskin, Bennett A. Shywitz,

Developmental Psychobiology

1984

21

Page 1